By David Wild
With its recent FDA approval, Vaxchora (PaxVax) has become the first U.S. vaccine for the prevention of cholera among travelers to cholera-endemic countries. Although that is a notable milestone, it remains to be seen how widely Vaxchora will be used and how much of an effect it will truly have, at least in this country.
“The incidence of cholera among Americans is miniscule,” commented travel medicine expert Christopher Sanford, MD, MPH, DTM&H, a clinical